Overview
Welcome to Dwaey, specifically on GONAPEPTYL CR 3.75mg Injection/Microcapsules page.
This medicine contains an important and useful components, as it consists of Triptorelin (as acetate).
GONAPEPTYL CR 3.75mg is available in the market in concentration 3.75mg/Syringe and in the form of Injection/Microcapsules.
FERRING GmbH is the producer of GONAPEPTYL CR 3.75mg and it is imported from GERMANY, The most popular alternatives of GONAPEPTYL CR 3.75mg are listed downward .
Triptorelin is a synthetic analogue of natural gonadotropin-releasing hormone. Initial admin stimulates the release of pituitary gonadotrophins with a transient increase in testosterone levels in men and in oestradiol levels in women, leading to an initial worsening of symptoms during the first wk. Prolonged admin leads to a suppression of gonadotrophins and a decrease in plasma testosterone or oestradiol after approximately 20 days, which is maintained for as long as triptorelin is admin.
Patients with pituitary adenoma; weight-related amenorrhoea until weight corrected; polycystic ovary disease or endometriotic cysts; metabolic bone disease. Monitor closely as there may be initial worsening of signs and symptoms during first few wk of therapy. Contraceptive measures to be taken to protect against unwanted ovulation in females.
Hypersensitivity to triptorelin and other luteinising hormone-releasing hormone (LHRH) or LHRH agonists; as sole treatment in prostate cancer patients with spinal cord compression or evidence of spinal metastases; progressive brain tumours in children. Pregnancy; lactation.
Pregnancy category: X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Triptorelin (as acetate)
Triptorelin (as acetate)